Esperion Therapeutics, Inc. (ESPR)
| Previous Close | 2.0600 |
| Open | 2.0600 |
| Bid | 0.0000 x 0 |
| Ask | 0.0000 x 0 |
| Day's Range | 2.0000 - 2.0600 |
| 52 Week Range | 0.7100 - 3.4000 |
| Volume | |
| Avg. Volume | 3,710,659 |
| Market Cap | 403.242M |
| Beta (5Y Monthly) | 1.00 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.8500 |
| Earnings Date | Nov 05, 2024 - Nov 11, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 7.59 |
GuruFocus.comMillennium Management LLC's Strategic Reduction in Esperion Therapeutics Inc Holdings
On September 30, 2024, Millennium Management LLC, a prominent hedge fund, made a significant adjustment to its investment portfolio by reducing its stake in Esperion Therapeutics Inc (NASDAQ:ESPR). This move is notable not only for its scale but also for the trading price of $1.65 per share, reflecting a strategic decision in the context of the firm's investment approach. Founded in 1989 by Israel Englander and Ronald Shear, Millennium Management LLC has evolved from a modest start-up with $35 million in seed money to a global hedge fund powerhouse.
Insider MonkeyIs Esperion Therapeutics, Inc. (ESPR) the Best NASDAQ Stock Under $5?
We recently compiled a list of 7 Best NASDAQ Stocks Under $5. In this article, we will look at where Esperion Therapeutics, Inc. (NASDAQ:ESPR) ranks among the best NASDAQ stocks under $5. Job Market Cools Yet Economists Remain Optimistic About Stability A Yahoo Finance report on September 28 reveals that consumers are beginning to feel […]
